Abstract:Background: Following the primary endothelial injury caused by cellular or humoral immunities against donor antigens, some non-polymorphic tissue antigens of allograft, which are not normally exposed to immune system, become accessible. Autoimmunities against these antigens may be involved in further tissue injury. Autoimmunities to collagen-V and vimentin have been found to be associated with graft dysfunction in lung and heart transplantation respectively. Since both collagen-V and vimentin are widely expressed in most connective tissues, we hypothesize that autoimmunities against collagen-V and vimentin are also associated with failure of other allografts. Methods: 121 kidney recipients who either had biopsy-proved graft injury or experienced rejection episodes were included in this study. Serum samples selected before occurrence of rejection episodes or biopsy-proven graft injury were tested for collagen-V and vimentin antibodies using Luminex technique. Donor specific antibody (DSA) against HLA A, B, or DR were tested using Labscreen Single Antigen Beads. The association between graft outcome and allo- or auto-antibodies were analyzed retrospectively. Results: The percentages of patients with collagen-V, vimentin, and donor-HLA antibodies were 21%, 45%, and 35% respectively. Mean fluorescence intensity of antibodies against collagen-V (962±710), vimentin (849±642) were significantly lower than that of HLA antibodies (7273±5407). 64% of HLA DSA+ patients had collagen-V and/or vimentin antibodies, while 46% of autoantibodies positive patients had HLA-DSAs. Presence of autoantibodies seemed to be significantly associated with HLA-DSAs (p< 0.05). Graft survival analysis demonstrated that DSA and autoantibody double negative patients had the highest 5-yr graft survival rate (61%, ref.), followed by those with only HLA-DSA (55%, p>0.05%), only autoantibody (47%, p>0.05), and double positive patients (12%, p< 0.01).[Figure 1]After adjustment for other predictors of graft failure, multivariate Cox analysis confirmed that the difference of graft survival rates between double negative and double positive patients was statistically significant. Conclusion: Collagen-V & vimentin antibodies were detected at low titers but high frequencies in renal graft recipients. Survival analysis suggested a synergistic effect of HLA-DSA and autoantibodies. HLA-A, B, or DR DSA were only detected in 46% of autoantibody+ patients, which suggested that these DSAs were not the only cause of primary endothelial injury resulting in secondary autoantibody responses. Cellular immunities or other alloantibodies (HLA-C, DP, DQ, or MICA- specific) might be also involved. Further studies are required to determine: 1) the time course of autoantibody development and its association with allospecific humoral and/or cellular immunities; 2) whether collagen-V and vimentin antibodies exist in failed or rejected allografts (elution of antibody from biopsy tissue); 3) the association of autoantibodies with biopsy-proven graft injury, especially chronic injury such as interstitial fibrosis.

Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat

Progressive Albuminuria and Glomerulosclerosis in A Rat Model of Chronic Renal-Allograft Rejection

Rat Renal Transplant Model for Mixed Acute Humoral and Cellular Rejection: Weak Correlation of Serum Cytokines/chemokines with Intragraft Changes.

Induction of Chronic Renal Allograft Dysfunction in a Rat Model with Complete and Exclusive MHC Incompatibility

Humoral Responses to Collagen-V and Vimentin Are Associated with Renal Graft Failure

Induction of Chronic Renal Allograft Injury by Injection of a Monoclonal Antibody Against a Donor MHC Ib Molecule in a Nude Rat Model

C4d as a significant predictor for humoral rejection in renal allografts.

Changes of hyaluronic acid,laminin and collagen typeⅣwithin the renal grafts and in serum during acute rejection

Acute cellular rejection of human renal tissue by adoptive transfer of allogeneic human peripheral blood mononuclear cells into chimeric rats: sequential gene expression of cytokines, chemokines and cytolytic effector molecules, and their regulation by CTLA-4-Ig

Preliminary Investigation of the Biomarkers of Acute Renal Transplant Rejection Using Integrated Proteomics Studies, Gene Expression Omnibus Datasets, and RNA Sequencing.

Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection

A rat model of chronic allograft liver rejection (vol 37, pg 2327, 2005)

Chronic allograft nephropathy in athymic nude rats after adoptive transfer of primed T lymphocytes.

Prevention of chronic renal allograft rejection by soluble CD83

Rejection of the Renal Allograft in the Absence of Demonstrable Antibody and Complement

Effects of FTY720 on Peripheral Blood Lymphocytes and Graft Infiltrating Cells in a Rat Model of Chronic Renal Allograft Rejection.

Chronic Rejection After Kidney Transplantation

Polymeric IgA antibody response to rabbit antithymocyte globulin in renal transplant recipients

Humoral Immunity-Mediated Chronic Rejection in Liver Transplantation is Associated with Predominant IL-10 Expression

Acute and Hyperacute Humoral Rejection in Kidney Allograft Recipients Treated with Anti-Human Thymocyte Antibodies

Late graft failure of pig‐to‐rhesus renal xenografts has features of glomerulopathy and recipients have anti‐swine leukocyte antigen class I and class II antibodies